NewsRx

Search our medical news database

Qiagen N.V.

Netherlands holding company reports increase in first quarter net sales

Published in Biotech Law Weekly, June 4th, 2004

Qiagen N.V. (QGENF) announced the results of operations for its first quarter and three-month period ended March 31, 2004.

The company reported that consolidated net sales for its first quarter 2004 increased 21% to $96.1 million, from $79.6 million for the same period in 2003.

Operating income for the quarter, including restructuring and relocation charges increased 12% to $18.1 million from $16.1 million in the comparable period in 2003, and net income for the quarter increased 4% to $11.4 million from $11.0 million in the same quarter of 2003.

Diluted earnings per share remained unchanged at $0.08, based on 148.8 million...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook